Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma-Reference-Cited by-同舟云学术

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma

Published:2009-11-10 Issue:12 Volume:101 Page:1995-2004
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Reardon D A,Dresemann G,Taillibert S,Campone M,van den Bent M,Clement P,Blomquist E,Gordower L,Schultz H,Raizer J,Hau P,Easaw J,Gil M,Tonn J,Gijtenbeek A,Schlegel U,Bergstrom P,Green S,Weir A,Nikolova Z

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605411.pdf

Reference47 articles.

1. Aloyz R, Grzywacz K, Xu ZY, Loignon M, Alaoui-Jamali MA, Panasci L (2004) Imatinib sensitizes CLL lymphocytes to chlorambucil. Leukemia 18: 409–414

2. Apte SM, Fan D, Killion JJ, Fidler IJ (2004) Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma. Clin Cancer Res 10: 897–908

3. Ballman KV, Buckner JC, Brown PD, Giannini C, Flynn PJ, LaPlant BR, Jaeckle KA (2007) The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. Neuro Oncol 9: 29–38

4. Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest 111: 1287–1295

5. Brandes AA, Tosoni A, Spagnolli F, Frezza G, Leonardi M, Calbucci F, Franceschi E (2008) Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology. Neuro Oncol 10: 361–367

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of precision oncology in adult glioblastoma;Molecular Oncology;2024-06-20

2. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21

3. Targeted Glioma Therapy—Clinical Trials and Future Directions;Pharmaceutics;2024-01-11

4. Glioblastoma;Physiology and Function of Glial Cells in Health and Disease;2023-12-18

5. Druggable genomic landscapes of high-grade gliomas;Frontiers in Medicine;2023-12-08